EC-0565

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameEC-0565
Drug Alias Namefolate-everolimus conjugate (Endocyte)EC-0565
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndocyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocyte Inc
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A